One of the excellent benefits of being a member of the Grants Academy is access to our bid writing drop-in surgeries.
These surgeries are held more or less fortnightly over lunch and are facilitated by Matthew Bennett plus other experienced senior academics.
They have been designed to offer members of the Grants Academy the opportunity to come along and to talk to experienced colleagues about their research, for example, getting advice on their ideas, how to strengthen their bids, etc.
I wanted to share some recent feedback from our latest session:
We got some very useful feedback and support. It couldn’t go better.
A group of two having 20 minutes each to explain about our interests. That was a tutorial!
The manner in which it took place was really very helpful with full attention being devoted to our two proposals in that time.
I would say that it was a great bid writing surgery!
If you are a Grants Academy member, and would like to attend any of the other sessions planned for this term, please contact Caroline O’Kane
Next dates:
10 Oct: 1.00 pm to 2.00 pm – Studland House, S401, Lansdowne
24 Oct: 1.00 pm to 2.00 pm – Casterbridge Room, Talbot
5 Nov: 12.00 pm to 1.00 pm – Casterbridge Room, Talbot
26 Nov: 1.00 pm to 2.00 pm – EBC, EB702, Lansdowne
10 Dec: 1.00 pm to 2.00 pm – EBC, EB203, Lansdowne
Want to find out more ? Find out more from the Grants Academy page on the blog.











New Nepal-based paper published last week
Congratulation to HEMS colleagues on their new book!
Book edited by BU academics published
BU Prof. Hundley in The Conversation
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease